| Name | Title | Contact Details |
|---|---|---|
Bruce Gray |
Chief Information and Digital Officer | Profile |
Ryan Zea |
Director of Emerging Technology | Profile |
Tod Wiederholt |
Director of Infrastructure Technology | Profile |
Tod Wiederholt |
Director, Infrastructure Technology | Profile |
Jill Gunnufson Buh |
Deputy Information System Security Officer | Profile |
Project House is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nebraska Heart Institute is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ClarVista Medical` based in Aliso Viejo` California is a leading developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing` ClarVista was spun out from Prospex Medical` a medical device incubator` to pursue the development of the HARMONI™ IOL. Between 2012 and 2014` the company developed the first generation HARMONI™ system` conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system` conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE.
Lawndale Christian Health Center is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.